BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Asuragen, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-651-0191 Fax: 512-721-4859


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
Company Profile For Asuragen, Inc. 8/15/2014 10:44:49 AM
Asuragen, Inc. Names Matthew McManus, M.D., Ph.D., President And CEO 8/5/2014 10:26:29 AM
Asuragen, Inc. Receives New York State License For Molecular Genetic And Oncology Clinical Laboratory Testing 7/10/2014 6:20:01 AM
Asuragen, Inc. Receives Notice of Patent Allowance for Broad Diagnostic Application of miR-21 in Cancer 10/8/2013 10:08:52 AM
Exiqon A/S and Asuragen, Inc. Sign Agreement for Real-Time PCR Services 6/10/2013 9:38:14 AM
Asuragen, Inc. Launches SuraSeq™ Next Generation Sequencing Panel in Its CAP Accredited CLIA Laboratory 5/30/2013 11:04:26 AM
Asuragen, Inc. Launches SuraSeq™ Next Generation Sequencing Services 4/4/2013 11:52:14 AM
Asuragen, Inc. Study Finds New Genetic Test Better Predicts Mother's Risk of Having a Child With Fragile X Syndrome 3/21/2013 11:20:15 AM
Asuragen, Inc. Collects $7.5 Million Financing 3/21/2013 9:20:34 AM
Rolland Carlson, Ph.D. Named CEO of Asuragen, Inc. 1/7/2013 8:05:50 AM
12345678